BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30515556)

  • 1. Normocytic anaemia is associated with systemic inflammation and poorer survival in patients with colorectal cancer treated with curative intent.
    McSorley ST; Johnstone M; Steele CW; Roxburgh CSD; Horgan PG; McMillan DC; Mansouri D
    Int J Colorectal Dis; 2019 Mar; 34(3):401-408. PubMed ID: 30515556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative data on red cell measures of iron status and their relation to the magnitude of the systemic inflammatory response and survival in patients with colorectal cancer.
    McSorley ST; Tham A; Steele CW; Dolan RD; Roxburgh CS; Horgan PG; McMillan DC
    Eur J Surg Oncol; 2019 Jul; 45(7):1205-1211. PubMed ID: 30850153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative anemia in colorectal cancer: relationships with tumor characteristics, systemic inflammation, and survival.
    Väyrynen JP; Tuomisto A; Väyrynen SA; Klintrup K; Karhu T; Mäkelä J; Herzig KH; Karttunen TJ; Mäkinen MJ
    Sci Rep; 2018 Jan; 8(1):1126. PubMed ID: 29348549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of anaemia in oesophago-gastric cancer patients undergoing curative treatment by means of neoadjuvant chemotherapy and surgery.
    Chan BY; McKinlay S; Forshaw M; MacDonald A; Maitra R; Orizu M; McSorley ST
    Surg Oncol; 2021 Sep; 38():101585. PubMed ID: 33930843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of preoperative anaemia and anaemic subtype on patient outcome in colorectal cancer.
    Tokunaga R; Nakagawa S; Miyamoto Y; Ohuchi M; Izumi D; Kosumi K; Taki K; Higashi T; Miyata T; Yoshida N; Baba H
    Colorectal Dis; 2019 Jan; 21(1):100-109. PubMed ID: 30230148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal Cancer, Systemic Inflammation, and Outcome: Staging the Tumor and Staging the Host.
    Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
    Ann Surg; 2016 Feb; 263(2):326-36. PubMed ID: 25575264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The yield of colorectal cancer among fast track patients with normocytic and microcytic anaemia.
    Panagiotopoulou IG; Fitzrol D; Parker RA; Kuzhively J; Luscombe N; Wells AD; Menon M; Bajwa FM; Watson MA
    Ann R Coll Surg Engl; 2014 May; 96(4):289-93. PubMed ID: 24780021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative anaemia and perioperative red blood cell transfusion as prognostic factors for recurrence and mortality in colorectal cancer-a Swedish cohort study.
    Mörner ME; Edgren G; Martling A; Gunnarsson U; Egenvall M
    Int J Colorectal Dis; 2017 Feb; 32(2):223-232. PubMed ID: 27770250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer.
    Wang F; He W; Jiang C; Guo G; Ke B; Dai Q; Long J; Xia L
    BMC Cancer; 2018 Nov; 18(1):1102. PubMed ID: 30419863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.
    Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
    Ann Surg; 2009 May; 249(5):788-93. PubMed ID: 19387324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between tumour stage, systemic inflammation, body composition and survival in patients with colorectal cancer.
    McSorley ST; Black DH; Horgan PG; McMillan DC
    Clin Nutr; 2018 Aug; 37(4):1279-1285. PubMed ID: 28566220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of systemic inflammatory and nutritional scores in colorectal cancer patients who underwent potentially curative resection.
    Tokunaga R; Sakamoto Y; Nakagawa S; Izumi D; Kosumi K; Taki K; Higashi T; Miyata T; Miyamoto Y; Yoshida N; Baba H
    Int J Clin Oncol; 2017 Aug; 22(4):740-748. PubMed ID: 28213742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer.
    Leitch EF; Chakrabarti M; Crozier JE; McKee RF; Anderson JH; Horgan PG; McMillan DC
    Br J Cancer; 2007 Nov; 97(9):1266-70. PubMed ID: 17923866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaemia and its impact on colorectal cancer patients: how can we better optimize surgical outcomes?
    Roberts V; Deftereos I; Mahbub B; Simons K; Faragher I; Chan STF; Yeung JM
    ANZ J Surg; 2021 May; 91(5):E280-E285. PubMed ID: 33851493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.
    Chan JC; Chan DL; Diakos CI; Engel A; Pavlakis N; Gill A; Clarke SJ
    Ann Surg; 2017 Mar; 265(3):539-546. PubMed ID: 27070934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Follow-Up of Patients Undergoing Resection of TNM Stage I Colorectal Cancer: An Analysis of Tumour and Host Determinants of Outcome.
    Mansouri D; Powell AG; Park JH; McMillan DC; Horgan PG
    World J Surg; 2016 Jun; 40(6):1485-91. PubMed ID: 26920405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of the Glasgow Prognostic Score or Modified Glasgow Prognostic Score for Patients with Colorectal Cancer Receiving Various Treatments: a Systematic Review and Meta-Analysis.
    He L; Li H; Cai J; Chen L; Yao J; Zhang Y; Xu W; Geng L; Yang M; Chen P; Zheng J; Yang Y; Gong S
    Cell Physiol Biochem; 2018; 51(3):1237-1249. PubMed ID: 30481755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer.
    Inoue Y; Iwata T; Okugawa Y; Kawamoto A; Hiro J; Toiyama Y; Tanaka K; Uchida K; Mohri Y; Miki C; Kusunoki M
    Oncology; 2013; 84(2):100-7. PubMed ID: 23147449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of anaemia at discharge following colorectal cancer surgery.
    Dru RC; Curtis NJ; Court EL; Spencer C; El Falaha S; Dennison G; Dalton R; Allison A; Ockrim J; Francis NK
    Int J Colorectal Dis; 2020 Sep; 35(9):1769-1776. PubMed ID: 32488418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.